Harff G A, Janssen W C, Rooijakkers M L
Department of Clinical Chemistry, Catharina Hospital, Eindhoven, The Netherlands.
Eur J Clin Chem Clin Biochem. 1997 Mar;35(3):241-2.
The performance of a new glucose electrode system from Radiometer was tested using two EML 105 analyzers (Radiometer Medical A/S, Copenhagen, Denmark). Results were very precise (both analyzers reported CV = 1.0% at a glucose concentration of 13.4 mmol/l). Comparison of methods was performed according to the NCCLS EP9-T guideline. Patients glucose results from both analyzers were lower compared with the results obtained with a Hitachi 911 (Boehringer Mannheim, Mannheim, Germany). There was no haematocrit dependency of relevance.
使用两台EML 105分析仪(丹麦哥本哈根雷度米特医疗公司)对雷度米特公司一款新型葡萄糖电极系统的性能进行了测试。结果非常精确(两台分析仪在葡萄糖浓度为13.4 mmol/l时报告的变异系数均为1.0%)。根据美国国家临床实验室标准委员会(NCCLS)的EP9-T指南进行了方法比较。与使用日立911分析仪(德国曼海姆宝灵曼公司)获得的结果相比,两台分析仪检测的患者葡萄糖结果均较低。不存在与血细胞比容相关的依赖性。